A comment on 'Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials'

被引：0
|
作者：
Goldenberg, Ronald M. [1 ,2 ]
机构：
[1] LMC Diabet & Endocrinol, Vaughan, ON, Canada
[2] LMC Diabet & Endocrinol, 1600 Steeles Ave West 5, Vaughan, ON L4K 4M2, Canada
来源：
DIABETES OBESITY & METABOLISM | 2024年 / 26卷 / 07期
关键词：
D O I：
10.1111/dom.15588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2997 / 2999
页数：3
相关论文
共 50 条
  • [41] Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials
    Wu, Sijin
    Lu, Wenzhao
    Chen, Zhongli
    Dai, Yan
    Chen, Keping
    Zhang, Shu
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [42] Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials
    Wong, Hon Jen
    Toh, Keith Zhi Xian
    Teo, Yao Hao
    Teo, Yao Neng
    Chan, Mark Y.
    Yeo, Leonard L. L.
    Eng, Pei Chia
    Tan, Benjamin Y. Q.
    Zhou, Xin
    Yang, Qing
    Dalakoti, Mayank
    Sia, Ching-Hui
    JOURNAL OF HYPERTENSION, 2025, 43 (02) : 290 - 300
  • [43] Erratum to: Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials
    Ilaria Dicembrini
    Besmir Nreu
    Alessia Scatena
    Francesco Andreozzi
    Giorgio Sesti
    Edoardo Mannucci
    Matteo Monami
    Acta Diabetologica, 2017, 54 : 1069 - 1071
  • [44] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Endoscopy Outcomes: A Systematic Review and Meta-Analysis
    Tariq, Raseen
    Naqvi, Syed Arsalan Ahmed
    Prokop, Larry J.
    Pardi, Darrell S.
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S592 - S593
  • [45] The effect of beinaglutide as an glucagon-like peptide-1 receptor agonists on cardiometabolic factors: a systematic review and meta-analysis
    Yan Xu
    Periyannan Velu
    Li Hu
    Nathalia Sernizon Guimarães
    Diabetology & Metabolic Syndrome, 17 (1):
  • [46] A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
    Chiu, Wei-Yih
    Shih, Shyang-Rong
    Tseng, Chin-Hsiao
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [47] Cholelithiasis in patients treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials
    Nreu, Besmir
    Dicembrini, Ilaria
    Tinti, Federico
    Mannucci, Edoardo
    Monami, Matteo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 161
  • [48] GLUCAGON-LIKE PEPTIDE-1 AGONISTS AND PROTECTION AGAINST STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Barkas, Fotios
    Elisaf, Moses
    Milionis, Haralampos
    ATHEROSCLEROSIS, 2017, 263 : E258 - E258
  • [49] A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists
    Hu, En-Hao
    Tsai, Ming-Lung
    Lin, Yuan
    Chou, Tien-Shin
    Chen, Tien-Hsing
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [50] The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: A systematic review and meta-analysis
    Maciel, Michel Garcia
    Soares Beserra, Bruna Teles
    Barroso Oliveira, Fernanda Cerqueira
    Ribeiro, Carolina Martins
    Coelho, Michella Soares
    Rocha Neves, Francisco de Assis
    Amato, Angelica Amorim
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 222 - 235
12345